Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry

Power to the Patients

Apr 09 2025 | 00:40:32

00:00 / 00:40:32

Show Notes

In this episode of Power to the Patients, Boehringer Ingelheim leaders Christine Sakdalan and Mike Jablonski from discuss how precision psychiatry—using tools like biomarkers and neuroimaging—can personalize treatment for conditions like schizophrenia and depression. They highlight the importance of holistic care, digital therapeutics, and industry collaboration to address unmet needs and improve outcomes in mental health.

Other Episodes

Episode 11

February 05, 2025 • 00:48:39

Unraveling Mysteries of the Brain Through Neuroscience Research

In this episode, Brandon Li sits down with Raymond Sanchez, former CMO of Cerevel, now at Bain Capital Life Sciences, to discuss the neuroscience...

Episode 2

May 12, 2025 • 00:42:17

Spyros Papapetropoulos, CEO of Neuphoria

Spyros Papapetropoulos, a leading neurologist and neuroscientist, joins Power CEO, Brandon Li, to discuss his remarkable career and the transformative work at Neuphoria. Spyros...

Episode 4

October 09, 2024 • 00:38:56

Why Beckley Psytech is Developing the Next Generation of Psychedelics

In this episode, Brandon Li sits down with Cosmo Feilding-Mellen, CEO of Beckley Psytech, to explore the groundbreaking work Beckley is doing in the...